Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. (Q44225011)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

Lourdes Grande

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Inés Camacho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Soledad Benitez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

José A Irles

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Manuel Castro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

781-787

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Partial pressure of ammonia versus ammonia in hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Ammonia production by intestinal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Distribution of glutaminase and glutamine synthetase activities in the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Glutamine metabolism by the intestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

The prognostic significance of subclinical hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with cirrhosis: a simplified method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Psychomotor performance defects in cirrhotic patients without overt encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Subclinical hepatic encephalopathy impairs daily functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Aminoacid utilization by Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Amino acid utilisation and deamination of glutamine and asparagine by Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900330-6

7 January 2021

10.1016/S0168-8278(02)00330-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12445419%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference